loadpatents
Patent applications and USPTO patent grants for Rousseau; Francois.The latest application filed is for "novel tnfr agonists and uses thereof".
Patent | Date |
---|---|
Readily isolated bispecific binding molecules with native format having mutated constant regions Grant 11,261,262 - Fischer , et al. March 1, 2 | 2022-03-01 |
Anti-CD47 antibodies and methods of use thereof Grant 11,059,910 - Masternak , et al. July 13, 2 | 2021-07-13 |
Anti-TLR4 antibodies and uses thereof Grant 10,982,004 - Rousseau , et al. April 20, 2 | 2021-04-20 |
Novel Tnfr Agonists And Uses Thereof App 20200347143 - BLEIN; Stanislas ;   et al. | 2020-11-05 |
Readily Isolated Bispecific Antibodies With Native Immunoglobulin Format App 20200231707 - FISCHER; Nicolas ;   et al. | 2020-07-23 |
Anti-tlr4 Antibodies And Uses Thereof App 20200207866 - Rousseau; Francois ;   et al. | 2020-07-02 |
Readily isolated bispecific antibodies with native immunoglobulin format Grant 10,494,446 - Fischer , et al. De | 2019-12-03 |
Anti-TLR4 antibodies and uses thereof Grant 10,400,044 - Rousseau , et al. Sep | 2019-09-03 |
Anti-cd47 Antibodies And Methods Of Use Thereof App 20180355065 - MASTERNAK; Krzysztof ;   et al. | 2018-12-13 |
Anti-cd47 Antibodies And Methods Of Use Thereof App 20180291115 - MASTERNAK; Krzysztof ;   et al. | 2018-10-11 |
Anti-cd47 Antibodies And Methods Of Use Thereof App 20180291116 - MASTERNAK; Krzysztof ;   et al. | 2018-10-11 |
Readily Isolated Bispecific Antibodies With Native Immunoglobulin Format App 20180057611 - FISCHER; Nicolas ;   et al. | 2018-03-01 |
Readily isolated bispecific antibodies with native immunoglobulin format Grant 9,815,909 - Fischer , et al. November 14, 2 | 2017-11-14 |
Anti-tlr4 Antibodies And Uses Thereof App 20170008967 - Rousseau; Francois ;   et al. | 2017-01-12 |
Nucleic acids encoding anti-IL-17F antibodies and methods of use thereof Grant 9,475,873 - Masternak , et al. October 25, 2 | 2016-10-25 |
Anti-TLR4 antibodies and uses thereof Grant 9,453,076 - Rousseau , et al. September 27, 2 | 2016-09-27 |
Readily Isolated Bispecific Binding Molecules with Native Format Having Mutated Constant Regions App 20150094451 - Fischer; Nicolas ;   et al. | 2015-04-02 |
Anti-CD47 Antibodies and Methods of Use Thereof App 20140303354 - Masternak; Krzysztof ;   et al. | 2014-10-09 |
Readily Isolated Bispecific Antibodies with Native Immunoglobulin Format App 20140051833 - Fischer; Nicolas ;   et al. | 2014-02-20 |
Methods of treatment using anti-IL-17F antibodies Grant 8,609,093 - Masternak , et al. December 17, 2 | 2013-12-17 |
Anti-TLR4 Antibodies and Uses Thereof App 20130315914 - Rousseau; Francois ;   et al. | 2013-11-28 |
Anti-il-17f Antibodies And Methods Of Use Thereof App 20120164152 - Masternak; Krzysztof ;   et al. | 2012-06-28 |
Anti-IL-17F antibodies Grant 8,137,671 - Masternak , et al. March 20, 2 | 2012-03-20 |
Anti-IL-17F Antibodies and Methods of Use Thereof App 20100285019 - Masternak; Krzysztof ;   et al. | 2010-11-11 |
Analyzer for the simultaneous enzymatic detection of closely related analytes App 20060099666 - Douville; Pierre ;   et al. | 2006-05-11 |
Marker at the androgen receptor gene for determining breast cancer susceptibility App 20060040263 - Rousseau; Francois | 2006-02-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.